All Articles

As Coinbase's CFO faces investors in London, can a story of bold innovation and strong growth overcome mounting regulatory and digital security risks?

GigaCloud Technology is acquiring New Classic Home Furnishings. We unpack the strategy behind this cash-rich tech firm's move into traditional retail.

The EU's new ResourceEU plan mobilizes billions to break foreign supply chain dominance, putting projects like Rock Tech's Guben lithium plant at the fore.

A new partnership merges AI automation with strategic consulting to ensure finance transformation projects deliver measurable ROI, not just new software.

The Danish biotech just locked in billions in financing for its Merus N.V. buyout. It's a high-stakes bet on a new cancer drug to redefine its future.

Bitwarden's new Access Intelligence aims to turn every employee into a security asset, tackling the biggest cause of corporate data breaches head-on.

A new, free tool from Distru and Metrc aims to solve the cannabis industry's labeling nightmare. Is this a game-changer for operators of all sizes?

Great American Media's theatrical leap for its new Christmas film isn't just a movie release—it's a strategic play to redefine holiday entertainment.

After a years-long battle over the $3.1B Verizon sale of Straight Path, IDT is cleared. We break down the court's surprising ruling and what it means.

A new PE firm is betting its strategy on data-driven leadership assessment. Can an algorithm for talent unlock the next wave of investment returns?

A top culinary award is more than a trophy. It's a testament to a flawless global supply chain and an operational blueprint for sustained perfection.

Beyond observability, Dynatrace's new AI agents and AWS specialization signal a strategic push into autonomous cloud operations. What does this mean for investors?

The biotech firm's latest private placement provides crucial cash but also brings heavy dilution and signals financial distress in a tough market.

A new fintech firm is using AI and non-custodial loans to bring instant liquidity to the art world's overlooked mid-market. Will it transform art into a dynamic asset?

From orphan drugs to the massive obesity market, we unpack Hoth Therapeutics' ambitious four-front strategy and the financial currents driving this biotech.

Lithos Carbon’s record delivery proves rock dust can remove CO2, boost farm profits, and set a new standard for the volatile carbon credit market.

An Aussie AI firm bets on a star hire and a risky SPAC merger to power sovereign AI. What does this mean for the infrastructure enabling healthcare's future?

Amid industry chaos, one egg producer's commitment to transparency and humane practices earned it a top award and offers a blueprint for purpose-driven profit.

By repaying debt early, Interpace signals a successful turnaround. See how financial discipline is fueling its focused push into thyroid diagnostics.

With a 60% dose reduction, Bayer's gadoquatrane could set a new safety standard and give the firm a strategic edge in a market under scrutiny.